Sanofi sues Eli Lilly over insulin rival to Lantus
July 08, 2014 at 13:13 PM EDT
July 8 (Reuters) - Sanofi SA, whose top-selling Lantus helps diabetics control blood sugar levels, has filed a lawsuit accusing Eli Lilly and Co of infringing seven patents related to insulin and devices used to deliver it.
